Clinical Trials on Healthy Patient Study

Total 25556 results

Hoffmann-La Roche

Completed

A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects

Healthy Patient Study

United Kingdom
Johns Hopkins University

Withdrawn

Home Visits for Patients at Risk for Appointment No-shows (SNAP HOME)

Engagement, Patient | Utilization, Health Care | No-Show Patients

United States
Mid Michigan Health Centers

Completed

Identification and Treatment of Men With BPH in the Primary Care Setting

No Conditions for This Study. All Male Patients 18 Years of Age or Older Were Administered the LUTS, MSHQ, and Patient Demographics Questionnaire

United States
Carmel Medical Center

Withdrawn

Back to Functional Life Following Cardiac Surgery (BTFL2012)

Cardiac Study Patients

Israel
National University Hospital, Singapore

Unknown

Adherence to Immunosuppressive Therapy Liver Transplant Recipients (AIM)

Focus : To Study the Differences in Patient Compliance to Immunosuppressive Treatments and Patient Preference.

Singapore
University of Cape Town

Withdrawn

Impact of Medical Follow-up Discharge Package (RECALL-CT)

Follow-up Study | Medical In-patients

South Africa
Atea Pharmaceuticals, Inc.

Recruiting

Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir

Healthy Volunteer Study

United States
BenevolentAI Bio

Completed

Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744.

Healthy Volunteer Study

United Kingdom
UCB Biopharma SRL

Completed

A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharamacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B

Healthy Study Participants

United States
Atea Pharmaceuticals, Inc.

Completed

The Study of Bemnifosbuvir in Healthy Japanese Subjects

Healthy Volunteer Study

United States
Atea Pharmaceuticals, Inc.

Completed

Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir (AT-527)

Healthy Volunteer Study

Canada
AstraZeneca
Parexel

Completed

Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab

Healthy Participants Study

Germany, United States, United Kingdom
UCB Biopharma SRL

Completed

A Study to Test Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of Zampilimab in Healthy Participants

Healthy Study Participants

United Kingdom
Atea Pharmaceuticals, Inc.
Hoffmann-La Roche

Completed

Effect of Cyclosporine on the Pharmacokinetics (PK) of AT-527 (R07496998)

Healthy Volunteer Study

Canada
Pfizer

Completed

Glasdegib Absolute Bioavailability Study

Healthy Volunteer Study

United States
Reckitt Benckiser Healthcare (UK) Limited
Simbec Research

Completed

Ibuprofen and Paracetamol Pharmacokinetic Study

Healthy Volunteer Study
Orion Corporation, Orion Pharma

Completed

Phase I Pharmacokinetic Study (SALBLOCK) (SALBLOCK)

Healthy Volunteer Study

Finland
University Hospital, Clermont-Ferrand

Completed

SUBclavian Central Venous Catheters Guidance and Examination by UltraSound (SUBGEUS)

Adult Patients | Requiring Subclavian Vein Cannulation | Patient Covered by French Health Care System

France
Atea Pharmaceuticals, Inc.

Not yet recruiting

Drug-drug Interaction Study of Biktarvy and Bemnifosbuvir/Ruzasvir

Healthy Volunteer Study

Canada
AstraZeneca

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants

Healthy Participants Study

United States
Comanche Biopharma

Recruiting

Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects

Healthy Volunteer Study

United States
BioAge Labs, Inc.

Completed

Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers

Healthy Volunteer Study

New Zealand
NewAmsterdam Pharma

Active, not recruiting

Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe

Healthy Volunteer Study

United States
Wake Forest University Health Sciences

Terminated

Efficacy of Spinal Oxytocin in Healthy Volunteers

Healthy Volunteer Study

United States
Atea Pharmaceuticals, Inc.
Hoffmann-La Roche

Completed

Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)

Healthy Volunteers Study

Canada
Atea Pharmaceuticals, Inc.
Hoffmann-La Roche

Completed

Study of AT-527 in Healthy Subjects (R07496998)

Healthy Volunteer Study

Canada
Denovo Biopharma LLC

Completed

A Study of LY2140023 in Healthy Participants

Healthy Volunteer Study

United Kingdom
UCB Biopharma SRL

Terminated

A Study to Evaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Healthy Study Participants

Healthy Study Participants

Germany
Atea Pharmaceuticals, Inc.
Hoffmann-La Roche

Completed

Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527

Healthy Volunteer Study

Canada
Atea Pharmaceuticals, Inc.
Hoffmann-La Roche

Completed

Drug-drug Interaction Study of Midazolam and AT-527 (R07496998)

Healthy Volunteer Study

Canada
UCB Biopharma SRL

Completed

Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

Healthy Study Participants

United States
Orion Corporation, Orion Pharma

Completed

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium (TIOBLOCK)

Healthy Volunteer Study

Finland
Dauntless Pharmaceuticals

Completed

Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

Healthy Volunteer Study

United States
Orion Corporation, Orion Pharma

Completed

Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers (FIMPAM)

Healthy Volunteer Study

Germany
Simbec Research

Completed

A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects

Healthy Volunteer Study

United Kingdom
Trident Pharmaceuticals Inc

Completed

Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers

Healthy Volunteer Study

United Kingdom
AstraZeneca

Completed

AZD8566 Food Effect/Microtracer Study

Healthy Volunteer Study

United Kingdom
UCB Biopharma SRL

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Rozanolixizumab Administered Subcutaneously Via Manual Push Versus Syringe Driver to Healthy Participants

Healthy Study Participants

United Kingdom
UCB Biopharma SRL

Completed

A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study Participants

Healthy Study Participants

United States, Germany
Atea Pharmaceuticals, Inc.

Completed

Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects

Healthy Volunteer Study

Canada
Atea Pharmaceuticals, Inc.

Completed

Study of AT-527 in Healthy Subjects Under Fasting Conditions or With a Meal

Healthy Volunteer Study

Canada
Atea Pharmaceuticals, Inc.
Hoffmann-La Roche

Completed

Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)

Healthy Volunteer Study

Canada
Atea Pharmaceuticals, Inc.
Hoffmann-La Roche

Completed

Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)

Healthy Volunteer Study

United States
UCB Biopharma S.P.R.L.

Terminated

A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants

Healthy Study Participants

United Kingdom
Exicure, Inc.

Completed

A Study of AST-008 in Healthy Subjects

Healthy Volunteer Study

United Kingdom
Reckitt Benckiser Healthcare (UK) Limited

Completed

Ibuprofen Suspension Bioequivalence Study

Healthy Volunteer Study

United Kingdom
University of Pennsylvania
M.D. Anderson Cancer Center; Massachusetts General Hospital; Washington University... and other collaborators

Completed

A Randomized Trial of Recruitment Strategies for Research Participation

Cancer | This Study Will Focus on Recruitment Strategies and Attitudes Towards Research Among Patients Considering Participation in 2 Parent Randomized Controlled Trials | Research Ethics

United States
University of Karachi
Center for Bioequivalence Studies and Clinical Research; Merck Pvt. Ltd, Pakistan

Completed

Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules (BE)

Healthy Volunteers | Bioequivalence Study

Pakistan
Endo Pharmaceuticals

Completed

Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers

Healthy Volunteer Safety Study

United States
AstraZeneca

Completed

A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers.

Healthy Volunteers Bioavailability Study

United Kingdom

Clinical Trials on Healthy Patient Study

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations